Line 6: |
Line 6: |
| *Leading to cell and tissue damage | | *Leading to cell and tissue damage |
| *It involves normal immune mechanisms directed towards harmless environmental antigens (ie. allergy) or directed at self antigens (ie. autoimmunity) | | *It involves normal immune mechanisms directed towards harmless environmental antigens (ie. allergy) or directed at self antigens (ie. autoimmunity) |
− | |l1=Hypersensitivity - WikiBlood#Introduction | + | |l1=Hypersensitivity - Introduction |
| |q2=Which two scientists proposed the mechanism for distinguishing between the different types of hypersensitivity reactions? | | |q2=Which two scientists proposed the mechanism for distinguishing between the different types of hypersensitivity reactions? |
| |a2=Gell and Coombs | | |a2=Gell and Coombs |
− | |l2=Hypersensitivity - WikiBlood#Introduction | + | |l2=Hypersensitivity - Introduction |
| |q3=Complete the following sentences | | |q3=Complete the following sentences |
| <p>Types I, II and III hypersensitivity are ??? reactions. Type IV hypersensitivity is a ??? reaction. </p> | | <p>Types I, II and III hypersensitivity are ??? reactions. Type IV hypersensitivity is a ??? reaction. </p> |
Line 15: |
Line 15: |
| *antibody mediated | | *antibody mediated |
| *cell mediated | | *cell mediated |
− | |l3=Hypersensitivity - WikiBlood#Classification | + | |l3=Hypersensitivity - Introduction#Classification |
| </FlashCard> | | </FlashCard> |
| ===Type I Hypersensitivity=== | | ===Type I Hypersensitivity=== |
Line 23: |
Line 23: |
| *Anaphylactic-mediated | | *Anaphylactic-mediated |
| *IgE-mediated | | *IgE-mediated |
− | |l1=Type I Hypersensitivity - WikiBlood#Introduction | + | |l1=Type I Hypersensitivity |
| |q2=What is the name of antigens which cause type I hypersensitivity? | | |q2=What is the name of antigens which cause type I hypersensitivity? |
| |a2=Allergens | | |a2=Allergens |
− | |l2=Type I Hypersensitivity - WikiBlood#Introduction | + | |l2=Type I Hypersensitivity#Introduction |
| |q3=Name some common allergens which cause a type I hypersensitivity reaction | | |q3=Name some common allergens which cause a type I hypersensitivity reaction |
| |a3= | | |a3= |
Line 34: |
Line 34: |
| *Proteins | | *Proteins |
| *Insect products | | *Insect products |
− | |l3=Type I Hypersensitivity - WikiBlood#Common allergens which elict a type I hypersensitivity reaction: | + | |l3=Type I Hypersensitivity#Common allergens which elict a type I hypersensitivity reaction: |
| |q4=Mast cells are caused to degranulate releasing cytokines. What affects do these cytokines have on the infected area? | | |q4=Mast cells are caused to degranulate releasing cytokines. What affects do these cytokines have on the infected area? |
| |a4= | | |a4= |
Line 42: |
Line 42: |
| *Chemoattractants cause the influx of [[Neutrophils|neutrophils]], basophils, [[[[Monocytes|monocytes]]]] and plasma | | *Chemoattractants cause the influx of [[Neutrophils|neutrophils]], basophils, [[[[Monocytes|monocytes]]]] and plasma |
| *Vasoactive and inflammatory peptides cause the contraction of smooth muscle fibres | | *Vasoactive and inflammatory peptides cause the contraction of smooth muscle fibres |
− | |l4=Type I Hypersensitivity - WikiBlood#Mechanism | + | |l4=Type I Hypersensitivity#Mechanism |
| |q5=Name some examples of type I hypsensitivity reactions | | |q5=Name some examples of type I hypsensitivity reactions |
| |a5= | | |a5= |
Line 48: |
Line 48: |
| *Atopy | | *Atopy |
| *Flea allergic dermatitis | | *Flea allergic dermatitis |
− | |l5=Type I Hypersensitivity - WikiBlood#Examples of Type I hypersensitivity | + | |l5=Type I Hypersensitivity#Examples of Type I hypersensitivity |
| </FlashCard> | | </FlashCard> |
| ===Type II Hypersensitivity=== | | ===Type II Hypersensitivity=== |
Line 57: |
Line 57: |
| *[[IgM]] | | *[[IgM]] |
| *Fixed antigens | | *Fixed antigens |
− | |l1=Type II Hypersensitivity - WikiBlood#Introduction | + | |l1=Type II Hypersensitivity#Introduction |
| |q2=What is the main mechanism of type II hypersensitivity reactions? | | |q2=What is the main mechanism of type II hypersensitivity reactions? |
| |a2=Neutralisation blockage of receptors | | |a2=Neutralisation blockage of receptors |
− | |l2=Type II Hypersensitivity - WikiBlood#Mechanism | + | |l2=Type II Hypersensitivity#Mechanism |
| |q3=Which immunological processes does the type II reaction use to destroy target cells? Give examples for each process? | | |q3=Which immunological processes does the type II reaction use to destroy target cells? Give examples for each process? |
| |a3= | | |a3= |
Line 72: |
Line 72: |
| **Feline infectious anaemia | | **Feline infectious anaemia |
| *Phagocytosis | | *Phagocytosis |
− | |l3=Type II Hypersensitivity - WikiBlood#Introduction | + | |l3=Type II Hypersensitivity#Introduction |
| </FlashCard> | | </FlashCard> |
| ===Type III Hypersensitivity=== | | ===Type III Hypersensitivity=== |
Line 80: |
Line 80: |
| *IgG | | *IgG |
| *Soluble antigens | | *Soluble antigens |
− | |l1=Type III Hypersensitivity - WikiBlood#Introduction | + | |l1=Type III Hypersensitivity#Introduction |
| |q2=What does inhaling antigen locally lead to? | | |q2=What does inhaling antigen locally lead to? |
| |a2=Hypersensitivity pneumonitis | | |a2=Hypersensitivity pneumonitis |
− | |l2=Type III Hypersensitivity - WikiBlood#Location of the immune complexes: | + | |l2=Type III Hypersensitivity#Location of the immune complexes: |
| |q3=What other conditions can be caused by a local type III hypersensitivity response? | | |q3=What other conditions can be caused by a local type III hypersensitivity response? |
| |a3= | | |a3= |
Line 90: |
Line 90: |
| *Vasculitis | | *Vasculitis |
| *Acute inflammation | | *Acute inflammation |
− | |l3=Type III Hypersensitivity - WikiBlood#Location of the immune complexes: | + | |l3=Type III Hypersensitivity#Location of the immune complexes: |
| |q4=What general effects does increased levels of systemic antigen have? | | |q4=What general effects does increased levels of systemic antigen have? |
| |a4= | | |a4= |
Line 98: |
Line 98: |
| *Neutropaenia | | *Neutropaenia |
| *Proteinurea | | *Proteinurea |
− | |l4=Type III Hypersensitivity - WikiBlood#Location of the immune complexes: | + | |l4=Type III Hypersensitivity#Location of the immune complexes: |
| |q5=Give an example of a type III hypersensitivity reaction where the antigen is a self antigen | | |q5=Give an example of a type III hypersensitivity reaction where the antigen is a self antigen |
| |a5=Systemic lupus erythematous (SLE) | | |a5=Systemic lupus erythematous (SLE) |
− | |l5=Type III Hypersensitivity - WikiBlood#Location of the immune complexes: | + | |l5=Type III Hypersensitivity#Location of the immune complexes: |
| </FlashCard> | | </FlashCard> |
| ===Type IV Hypersensitivity=== | | ===Type IV Hypersensitivity=== |
Line 107: |
Line 107: |
| |q1=What is type IV hypersensitivity also known as? | | |q1=What is type IV hypersensitivity also known as? |
| |a1=Delayed-type hypersensitivity | | |a1=Delayed-type hypersensitivity |
− | |l1=Type IV Hypersensitivity - WikiBlood#Introduction | + | |l1=Type IV Hypersensitivity#Introduction |
| |q2=What effects do a CD4+ helper cell hypersensitivity response have? | | |q2=What effects do a CD4+ helper cell hypersensitivity response have? |
| |a2= | | |a2= |
| *Abnormal macrophage activation | | *Abnormal macrophage activation |
| *Macrophage production of inflammatory mediators and MMP (matrix metalloproteinase) | | *Macrophage production of inflammatory mediators and MMP (matrix metalloproteinase) |
− | |l2=Type IV Hypersensitivity - WikiBlood#Introduction | + | |l2=Type IV Hypersensitivity#Introduction |
| |q3=What effect does a CD8+ cytotoxic hypersensitivity response have? | | |q3=What effect does a CD8+ cytotoxic hypersensitivity response have? |
| |a3=Destruction of normal cells | | |a3=Destruction of normal cells |
− | |l3=Type IV Hypersensitivity - WikiBlood#Introduction | + | |l3=Type IV Hypersensitivity#Introduction |
| |q4=What are the two types of type IV hypersensitivity reactions? | | |q4=What are the two types of type IV hypersensitivity reactions? |
| |a4= | | |a4= |
| *Contact | | *Contact |
| *Granulomatous | | *Granulomatous |
− | |l4=Type IV Hypersensitivity - WikiBlood#2 types: | + | |l4=Type IV Hypersensitivity#2 types: |
| |q5=What are the main cells involved in contact dermatitis? | | |q5=What are the main cells involved in contact dermatitis? |
| |a5=Mononuclear cells | | |a5=Mononuclear cells |
− | |l5=Type IV Hypersensitivity - WikiBlood#1. Contact | + | |l5=Type IV Hypersensitivity#1. Contact |
| |q6=Give two examples of infections causing a granulomatous response | | |q6=Give two examples of infections causing a granulomatous response |
| |a6= | | |a6= |
| *Mycobacterium tubercle | | *Mycobacterium tubercle |
| *Schistosome eggs | | *Schistosome eggs |
− | |l6=Type IV Hypersensitivity - WikiBlood#2. Granulomatous | + | |l6=Type IV Hypersensitivity#2. Granulomatous |
| |q7=What is the tuberculin test? | | |q7=What is the tuberculin test? |
| |a7= | | |a7= |
Line 134: |
Line 134: |
| *Injection of intradermal antigen into the skin | | *Injection of intradermal antigen into the skin |
| *A skin reaction (infiltration of lymphocytes and [[[[Monocytes|monocytes]]]]) peaking at 48-72 hours indicates prior exposure to the antigen or ongoing infection | | *A skin reaction (infiltration of lymphocytes and [[[[Monocytes|monocytes]]]]) peaking at 48-72 hours indicates prior exposure to the antigen or ongoing infection |
− | |l7=Type IV Hypersensitivity - WikiBlood#2. Granulomatous | + | |l7=Type IV Hypersensitivity#2. Granulomatous |
| </FlashCard> | | </FlashCard> |
| | | |